Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(4):445–450. doi: 10.1038/bjc.1997.408

Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts.

Y Takamiya 1, Y Abe 1, Y Tanaka 1, A Tsugu 1, M Kazuno 1, Y Oshika 1, K Maruo 1, Y Ohnishi 1, O Sato 1, H Yamazaki 1, H Kijima 1, Y Ueyama 1, N Tamaoki 1, M Nakamura 1
PMCID: PMC2227999  PMID: 9275020

Abstract

Human glioma usually shows intrinsic multidrug resistance because of the blood-brain barrier (BBB), in which membrane-associated P-glycoprotein (P-gp), encoded by the human multidrug resistance gene MDR1, plays a role. We studied drug sensitivity to vincristine (VCR), doxorubicin (DOX) and nimustine (ACNU) in both intracerebrally and subcutaneously xenotransplanted human glioma. We examined the levels of MDR1 and murine mdr3 gene expression in the xenografts by reverse transcriptase polymerase chain reaction and the localization of P-gp by immunohistochemistry. Six of seven subcutaneously transplanted xenografts (scX) were sensitive to the above three drugs. In contrast, all three intracerebrally transplanted human glioma xenografts (icX) were resistant to P-gp-mediated drugs VCR and DOX, but were sensitive to the non-P-gp-mediated drug ACNU. Neither icX nor scX showed any MDR1 expression. Intracerebrally transplanted human glioma xenografts showed an increased level of murine mdr3 gene expression, whereas scX showed only faint expression. The localization of P-gp was limited to the stromal vessels in icX by immunohistochemistry, whereas scX expressed no P-gp. Our findings suggest that the P-gp expressed on the stromal vessels in icX is a major contributing factor to multidrug resistance in human glioma in vivo.

Full text

PDF
445

Images in this article

447Figure 1
on p.447
448Figure 3
on p.448
448Figure 2
on p.448

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe Y., Nakamura M., Saegusa R., Ueyama Y., Ogata T., Tamaoki N. In vivo acquired drug resistance and multidrug resistance gene (MDR1) expression in the KB carcinoma cell line xenotransplanted in nude mice. Tokai J Exp Clin Med. 1993 Dec;18(3-6):99–106. [PubMed] [Google Scholar]
  2. Abe Y., Ohnishi Y., Yoshimura M., Ota E., Ozeki Y., Oshika Y., Tokunaga T., Yamazaki H., Ueyema Y., Ogata T. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Br J Cancer. 1996 Dec;74(12):1929–1934. doi: 10.1038/bjc.1996.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abe Y., Yamazaki H., Oshika Y., Suto R., Tsugu A., Ota E., Satoh H., Ohnishi Y., Yanagawa T., Ueyama Y. Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in a human epidermoid carcinoma xenograft. Anticancer Res. 1996 Mar-Apr;16(2):729–734. [PubMed] [Google Scholar]
  4. Ausman J. I., Shapiro W. R., Rall D. P. Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res. 1970 Sep;30(9):2394–2400. [PubMed] [Google Scholar]
  5. Becker I., Becker K. F., Meyermann R., Höllt V. The multidrug-resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol. 1991;82(6):516–519. doi: 10.1007/BF00293387. [DOI] [PubMed] [Google Scholar]
  6. Boesch D., Gavériaux C., Jachez B., Pourtier-Manzanedo A., Bollinger P., Loor F. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res. 1991 Aug 15;51(16):4226–4233. [PubMed] [Google Scholar]
  7. Chen C. J., Chin J. E., Ueda K., Clark D. P., Pastan I., Gottesman M. M., Roninson I. B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986 Nov 7;47(3):381–389. doi: 10.1016/0092-8674(86)90595-7. [DOI] [PubMed] [Google Scholar]
  8. Chen C. J., Clark D., Ueda K., Pastan I., Gottesman M. M., Roninson I. B. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem. 1990 Jan 5;265(1):506–514. [PubMed] [Google Scholar]
  9. Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R., Bertino J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989 Jan;86(2):695–698. doi: 10.1073/pnas.86.2.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Edwards M. S., Levin V. A., Wilson C. B. Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. Cancer Treat Rep. 1980;64(12):1179–1205. [PubMed] [Google Scholar]
  11. Gros P., Ben Neriah Y. B., Croop J. M., Housman D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 1986 Oct 23;323(6090):728–731. doi: 10.1038/323728a0. [DOI] [PubMed] [Google Scholar]
  12. Gros P., Raymond M., Bell J., Housman D. Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol. 1988 Jul;8(7):2770–2778. doi: 10.1128/mcb.8.7.2770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hegmann E. J., Bauer H. C., Kerbel R. S. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res. 1992 Dec 15;52(24):6969–6975. [PubMed] [Google Scholar]
  14. Inaba M., Kobayashi T., Tashiro T., Sakurai Y., Maruo K., Ohnishi Y., Ueyama Y., Nomura T. Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose. Cancer. 1989 Oct 15;64(8):1577–1582. doi: 10.1002/1097-0142(19891015)64:8<1577::aid-cncr2820640803>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  15. Kadam S., Maus M., Poddig J., Schmidt S., Rasmussen R., Novosad E., Plattner J., McAlpine J. Reversal of multidrug resistance by two novel indole derivatives. Cancer Res. 1992 Sep 1;52(17):4735–4740. [PubMed] [Google Scholar]
  16. Kornblith P. L., Walker M. Chemotherapy for malignant gliomas. J Neurosurg. 1988 Jan;68(1):1–17. doi: 10.3171/jns.1988.68.1.0001. [DOI] [PubMed] [Google Scholar]
  17. Levin V. A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem. 1980 Jun;23(6):682–684. doi: 10.1021/jm00180a022. [DOI] [PubMed] [Google Scholar]
  18. Long D. M. Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J Neurosurg. 1970 Feb;32(2):127–144. doi: 10.3171/jns.1970.32.2.0127. [DOI] [PubMed] [Google Scholar]
  19. Maruo K., Ueyama Y., Inaba M., Emura R., Ohnishi Y., Nakamura O., Sato O., Nomura T. Responsiveness of subcutaneous human glioma xenografts to various antitumor agents. Anticancer Res. 1990 Jan-Feb;10(1):209–212. [PubMed] [Google Scholar]
  20. Matsumoto T., Tani E., Kaba K., Kochi N., Shindo H., Yamamoto Y., Sakamoto H., Furuyama J. Amplification and expression of a multidrug resistance gene in human glioma cell lines. J Neurosurg. 1990 Jan;72(1):96–101. doi: 10.3171/jns.1990.72.1.0096. [DOI] [PubMed] [Google Scholar]
  21. Mickisch G. H., Pai L. H., Gottesman M. M., Pastan I. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice. Cancer Res. 1992 Aug 15;52(16):4427–4432. [PubMed] [Google Scholar]
  22. Miyamoto K., Inoko K., Wakusawa S., Kajita S., Hasegawa T., Takagi K., Koyama M. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo. Cancer Res. 1993 Apr 1;53(7):1555–1559. [PubMed] [Google Scholar]
  23. Nabors M. W., Griffin C. A., Zehnbauer B. A., Hruban R. H., Phillips P. C., Grossman S. A., Brem H., Colvin O. M. Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg. 1991 Dec;75(6):941–946. doi: 10.3171/jns.1991.75.6.0941. [DOI] [PubMed] [Google Scholar]
  24. Noonan K. E., Beck C., Holzmayer T. A., Chin J. E., Wunder J. S., Andrulis I. L., Gazdar A. F., Willman C. L., Griffith B., Von Hoff D. D. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7160–7164. doi: 10.1073/pnas.87.18.7160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Parnes J. R., Seidman J. G. Structure of wild-type and mutant mouse beta 2-microglobulin genes. Cell. 1982 Jun;29(2):661–669. doi: 10.1016/0092-8674(82)90182-9. [DOI] [PubMed] [Google Scholar]
  26. Reese T. S., Karnovsky M. J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 1967 Jul;34(1):207–217. doi: 10.1083/jcb.34.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schinkel A. H., Smit J. J., van Tellingen O., Beijnen J. H., Wagenaar E., van Deemter L., Mol C. A., van der Valk M. A., Robanus-Maandag E. C., te Riele H. P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994 May 20;77(4):491–502. doi: 10.1016/0092-8674(94)90212-7. [DOI] [PubMed] [Google Scholar]
  28. Shapiro W. R., Basler G. A., Chernik N. L., Posner J. B. Human brain tumor transplantation into nude mice. J Natl Cancer Inst. 1979 Mar;62(3):447–453. doi: 10.1093/jnci/62.3.447. [DOI] [PubMed] [Google Scholar]
  29. Shapiro W. R., Yung W. A., Basler G. A., Shapiro J. R. Heterogeneous response to chemotherapy of human gliomas grown in nude mice and as clones in vitro. Cancer Treat Rep. 1981;65 (Suppl 2):55–59. [PubMed] [Google Scholar]
  30. Sugawara I., Hamada H., Tsuruo T., Mori S. Specialized localization of P-glycoprotein recognized by MRK 16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn J Cancer Res. 1990 Aug;81(8):727–730. doi: 10.1111/j.1349-7006.1990.tb02636.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tanaka Y., Abe Y., Tsugu A., Takamiya Y., Akatsuka A., Tsuruo T., Yamazaki H., Ueyama Y., Sato O., Tamaoki N. Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas. Virchows Arch. 1994;425(2):133–138. doi: 10.1007/BF00230349. [DOI] [PubMed] [Google Scholar]
  32. Tatsuta T., Naito M., Oh-hara T., Sugawara I., Tsuruo T. Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem. 1992 Oct 5;267(28):20383–20391. [PubMed] [Google Scholar]
  33. Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7735–7738. doi: 10.1073/pnas.84.21.7735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tóth K., Vaughan M. M., Slocum H. K., Arredondo M. A., Takita H., Baker R. M., Rustum Y. M. New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. Am J Pathol. 1994 Feb;144(2):227–236. [PMC free article] [PubMed] [Google Scholar]
  35. UKCCCR guidelines for the welfare of animals in experimental neoplasia. Br J Cancer. 1988 Jul;58(1):109–113. doi: 10.1038/bjc.1988.174. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES